After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
AUPH belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Aurinia Pharmaceuticals Inc is $1.71B. A total of 0.87 million shares were traded on the day, compared to an average of 2.17M shares.
In the most recent transaction, TANG KEVIN bought 1,000,000 shares of AUPH for 10.12 per share on Aug 01 ’25. After the transaction, the Director now owns 11,029,500 company shares. In a previous transaction on Aug 05 ’25, TANG KEVIN bought 200,000 shares at 11.68 per share. AUPH shares that Director owns now total 11,329,500.
Among the insiders who bought shares, TANG KEVIN acquired of 100,000 shares on Aug 04 ’25 at a per-share price of $11.34. This resulted in the Director holding 11,129,500 shares of AUPH after the transaction. In another insider transaction, Keenan Greg sold 20,000 shares at $10.50 per share on Aug 01 ’25. Company shares held by the Chief Medical Officer now total 133,484.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, AUPH has a high of $13.44 and a low of $6.55.
As of this writing, AUPH has an earnings estimate of $0.16 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of $0.21 per share and a lower estimate of $0.1. The company reported an EPS of $0.1 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. AUPH’s latest balance sheet shows that the firm has $466.08M in Cash & Short Term Investments as of fiscal 2021. There were $8.74M in debt and $40.65M in liabilities at the time. Its Book Value Per Share was $2.53, while its Total Shareholder’s Equity was $479.09M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AUPH is Buy with a score of 4.25.
